Mercado europeo de cultivos celulares automatizados: tendencias de la industria y pronóstico hasta 2029

Solicitud de índiceSolicitud de índice Hable con el analistaHable con el analista Comprar ahoraComprar ahora Consultar antes de comprarConsultar antes Informe de muestra gratuitoInforme de muestra gratuito

Mercado europeo de cultivos celulares automatizados: tendencias de la industria y pronóstico hasta 2029

  • Healthcare
  • Published Report
  • Sep 2022
  • Europe
  • 350 Páginas
  • Número de tablas: 184
  • Número de figuras: 35

>Mercado europeo de cultivos celulares automatizados, por producto (consumibles, instrumentos), tipo (cultivos de líneas celulares infinitas, cultivos de líneas celulares finitas), aplicación (desarrollo de fármacos, investigación con células madre, medicina regenerativa , investigación del cáncer, vacunas , otros), usuario final (empresas de biotecnología, organizaciones de investigación, institutos de investigación académica, otros), tendencias de la industria y pronóstico hasta 2029.

Mercado europeo de cultivos celulares automatizados

Análisis y perspectivas del mercado de cultivos celulares automatizados en Europa

El informe de mercado de cultivos celulares automatizados proporciona detalles de la participación de mercado, nuevos desarrollos y análisis de la cartera de productos, el impacto de los actores del mercado nacional y localizado, analiza las oportunidades en términos de bolsillos de ingresos emergentes, cambios en las regulaciones del mercado, aprobaciones de productos, decisiones estratégicas, lanzamientos de productos, expansiones geográficas e innovaciones tecnológicas en el mercado. Para comprender el análisis y el escenario del mercado, contáctenos para obtener un informe de analista; nuestro equipo lo ayudará a crear una solución de impacto en los ingresos para lograr su objetivo deseado.

Mercado europeo de cultivos celulares automatizados

Mercado europeo de cultivos celulares automatizados

Se espera que el mercado europeo de cultivos celulares automatizados gane crecimiento de mercado en el período de pronóstico de 2022 a 2029. Data Bridge Market Research analiza que el mercado está creciendo con una CAGR del 8,2% en el período de pronóstico de 2022 a 2029 y se espera que alcance los 5.807,17 millones de euros para 2029. La creciente demanda de tecnología de cultivo celular en la producción de vacunas y la amplia aceptación de las técnicas de cultivo celular en diversas aplicaciones son los principales impulsores que impulsaron la demanda del mercado en el período de pronóstico.

Métrica del informe

Detalles

Período de pronóstico

2022 a 2029

Año base

2021

Años históricos

2020 (Personalizable para 2019 - 2014)

Unidades cuantitativas

Ingresos en millones de euros, volúmenes en unidades, precios en euros

Segmentos cubiertos

Por producto (consumibles, instrumentos), tipo (cultivos de líneas celulares infinitas, cultivos de líneas celulares finitas), aplicación (desarrollo de fármacos, investigación con células madre, medicina regenerativa , investigación del cáncer, vacunas , otros), usuario final (empresas de biotecnología, organizaciones de investigación, institutos de investigación académica, otros)

Países cubiertos

Alemania, Reino Unido, Francia, Rusia, Italia, Turquía, Países Bajos, Suiza, España, Bélgica y resto de Europa.

Actores del mercado cubiertos

Lonza, Merck KGaA, Thermo Fisher Scientific Inc., BD, Eppendorf AG y otros

Definición del mercado europeo de cultivos celulares automatizados

Automated cell culture systems are instruments that mechanically carries out the steps involved in growing and maintaining a cell culture. Useful in any lab that works with cell biology, cell signaling, protein expression, or drug discovery, an automated cell culture system helps to grow cell cultures while saving labor time and reducing errors. Automated cell culture systems can be capable of diluting samples, growing cultures in liquid with constant swirling, plating cultures, or placing cultures in wells. Increase in demand for 3D cell cultures, increasing collaboration among market players, and increasing outsourcing facilities are expected to provide a lucrative growth opportunity for the market. However, high cost of automated cell culture systems, and limitations associated with automated cell cultures are the factors expected to restraint the market growth in the forecast period.

Europe Automated Cell Cultures Market Dynamics

This section deals with understanding the market drivers, opportunity, restraint, and challenge. All of this is discussed in detail below:

  • Drivers

Increasing Demand for Cell Culture Technology in Vaccine Production

Cell culture is an essential tool for molecular and cellular biology research. Today, most biotechnology products primarily rely on mass culturing cell lines. Cell cultures have applications in diverse areas and serve as a model system for numerous research efforts.

An increase in funding from the government for cell-based research is significantly triggering the market's growth. In addition, cell culture techniques are widely being used as an alternative to current egg-based strategies for developing cell-based vaccines. Cell culture has potential applications in developing viral vaccines with increased communicable diseases and pandemic risk. Thus, cell culture technology is being extensively used in developing U.S. licensed vaccines such as vaccines against rubella, smallpox, chickenpox, hepatitis, rotavirus, and polio.

Technological Advancements in Cell Culture Technology Systems

As the demand for advanced cell culture technologies in vaccine production, cancer research, and virology, among others, is increasing, certain technological developments are taking place in automated cell culture.

Thus, market players operating in the market adopt various technological developments in cell culture equipment to boost their business in various dimensions and lead to market growth. This factor could drive the Europe automated cell cultures market growth.

  • Restraint

High Cost of Automated Cell Culture Systems

The cost of the product is the major setback for the market as it is expected to decrease the demand due to high cost. In the case of automated cell culture systems, the price is also high, and below the given instance will showcase the product's price.

The instruments and consumables-related products such as cell counters, reagents, buffers, and others have high prices, which shows that the cost of automated cell cultures is the primary factor expected to restrain the Europe automated cell cultures market in the forecasted period.

  • Opportunity

New Product Launches and Technology Developments

Pharmaceutical and biotechnology-driven companies are working towards developing and launching new products and technologies for automated cell culture advancement and making the treatment and diagnosis methods more reachable. This has also increased the demand for an automated cell culture market for 3D cell cultures. The development of new bioreactors, platforms, software’s has led to an advancement in the automated cell culture market and its growth.

The new products and technologies launched and worked upon create good opportunities for the Europe automated cell cultures market. The new platforms with advanced technologies act as a footstep closer to the advancement of the market.

  • Challenge

Development and Maintenance of Expertise

Recruitment and retention of trained and qualified staff, staff development, capital budgets for equipment purchase, operating budget management, facility infrastructure, and change management all require proper attention for the growth and success of any market. Failure to meet needs in any of these areas can lead to a serious weakness that, if uncorrected, may compromise the credibility of a laboratory and create a situation that will be difficult to correct in the short term.

Testing and maintaining the level of expertise in testing laboratories is a tough task, and it needs high experience, which sometimes is not accessible, which causes the development process for a particular company to hinder. Thus it is anticipated to challenge the Europe automated cell cultures market growth in the forecasted period.

Recent Developments

  • In July 2021, the life science group Sartorius, Sartorius Stadium Biotech subgroup, acquired a majority stake in the reagent manufacturer CellGenix GmbH.
  • In December 2O2O, Eppendorf presented the new modular bioreactor control system SciVario twin to its bioprocess customers in 2020. Designed to provide more flexibility in the laboratory, it allows users to control two glass bioreactors in the volume range of 0.2 to 40 liters individually or in parallel from a computer or tablet using Eppendorf’s software VisioNize – without the need to change the configuration of the hardware.

Europe Automated Cell Cultures Market Scope

Europe automated cell cultures market is segmented into Product, Type, Application, and End User. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

Europe Automated Cell Cultures Market, By Product

  • Consumables
  • Instruments

On the basis of product, the Europe automated cell cultures market is segmented into consumables and instruments

Europe Automated Cell Cultures Market, By Type

  • Infinite Cell Line Cultures
  • Finite Cell Line Cultures

On the basis of type, the Europe automated cell cultures market is segmented into infinine Cell line cultures and finite Cell line cultures

Europe Automated Cell Cultures Market, By Application

  • Drug Development
  • Stem Cell Research
  • Regenerative Medicine
  • Cancer Research
  • Vaccines
  • Other

On the basis of application, the Europe automated cell cultures market is segmented into drug development, stem cell research, regenerative medicine, cancer research, vaccine and other.

Europe Automated Cell Cultures Market, By End User

  • Biotech Companies
  • Research Organizations
  • Academic Research Institutes
  • Other

Mercado de cultivos celulares automatizados

On the basis of end user, the Europe automated cell cultures market is segmented into biotech companies, research organizations, academic research institutes and other.

Europe Automated Cell Cultures Market Regional Analysis/Insights

The Europe automated cell cultures market is analyzed and market size information is provided by Product, Type, Application, and End User.

The countries covered in this market report are Germany, U.K., France, Russia, Italy, Turkey, Netherlands, Switzerland, Spain, Belgium and rest of Europe.

  • In 2022, Europe automated cell cultures market is expected to grow due to increasing applications in stem cell research, vaccine production, regenerative medicines production, and drug discovery.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Europe Automated Cell Cultures Market Share Analysis

Europe automated cell cultures market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus on the Europe automated cell cultures market.

Los actores clave del mercado de cultivos celulares automatizados en Europa son Lonza, Merck KGaA, Thermo Fisher Scientific Inc., BD, Eppendorf AG, Advanced Instruments, Benchmark scientific, Inc., BioSpherix, Ltd., Biotron Healthcare, Bulldog Bio, Cell Culture Company, LLC, CellGenix GmbH, ChemoMetec, Corning Incorporated, Cytiva (subsidiaria de Danahar Corporation), FUJIFILM Holdings America Corporation, Hemilton Company, Hitachi, Ltd., Kawasaki Heavy Industries, ltd., HiMedia Laboratories, NanoEntek America, Inc., Nexcelom Bioscience LLC., PromoCell GmbH, RWD Life Science Co., LTD, Sartorius AG, Scientica Instrumentation, Inc., SHIBUYA CORPORATION, Sphere Fluidics Limited, Tecan Trading AG, Thrive Bioscience, Inc. y otros.

  • Metodología de investigación: mercado europeo de cultivos celulares automatizados

La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con tamaños de muestra grandes. Los datos del mercado se analizan y estiman utilizando modelos estadísticos y coherentes del mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Aparte de esto, los modelos de datos incluyen la cuadrícula de posicionamiento de proveedores, el análisis de la línea de tiempo del mercado, la descripción general y la guía del mercado, la cuadrícula de posicionamiento de la empresa, el análisis de la participación de mercado de la empresa, los estándares de medición, Europa frente a la región y el análisis de la participación de los proveedores. Solicite una llamada de un analista en caso de tener más consultas.


SKU-

Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo

  • Panel de análisis de datos interactivo
  • Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
  • Acceso de analista de investigación para personalización y consultas
  • Análisis de la competencia con panel interactivo
  • Últimas noticias, actualizaciones y análisis de tendencias
  • Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia
Solicitud de demostración

Tabla de contenido

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET APPLICATION COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 REGULATORY FRAMEWORK FOR EUROPE AUTOMATED CELL CULTURES MARKET

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASING DEMAND FOR CELL CULTURE TECHNOLOGY IN VACCINE PRODUCTION

6.1.2 TECHNOLOGICAL ADVANCEMENTS IN CELL CULTURE TECHNOLOGY SYSTEMS

6.1.3 WIDE ACCEPTANCE OF CELL CULTURE TECHNIQUES IN VARIOUS APPLICATIONS

6.1.4 GROWING BIOTECHNOLOGY SECTOR, ALONG WITH RISING HEALTHCARE EXPENDITURE

6.1.5 ADVANTAGES OF AUTOMATED CELL CULTURE SYSTEMS OVER MANUAL METHODS

6.2 RESTRAINTS

6.2.1 HIGH COST OF AUTOMATED CELL CULTURE SYSTEMS

6.2.2 LIMITATIONS ASSOCIATED WITH AUTOMATED CELL CULTURES

6.2.3 MAINTENANCE AND UPDATING OF EQUIPMENT

6.2.4 LACK OF SKILLED AND CERTIFIED PROFESSIONALS

6.3 OPPORTUNITIES

6.3.1 NEW PRODUCT LAUNCHES AND TECHNOLOGY DEVELOPMENTS

6.3.2 INCREASING COLLABORATION AMONG MARKET PLAYERS

6.3.3 INCREASING OUTSOURCING FACILITIES

6.3.4 INCREASE IN DEMAND FOR 3D CELL CULTURE

6.4 CHALLENGES

6.4.1 DEVELOPMENT AND MAINTENANCE OF EXPERTISE

6.4.2 LACK OF INFRASTRUCTURE FOR CELL-BASED RESEARCH IN EMERGING ECONOMIES

7 EUROPE AUTOMATED CELL CULTURES MARKET, BY PRODUCT

7.1 OVERVIEW

7.2 CONSUMABLES

7.2.1 MEDIA

7.2.1.1 SERUM FREE MEDIA

7.2.1.2 CLASSICAL MEDIA & SALTS

7.2.1.3 STEM CELL CULTURE MEDIA

7.2.1.4 SPECIALTY MEDIA

7.2.2 BUFFERS AND SUPPLEMENTS

7.2.2.1 PLASMA

7.2.2.2 SERA

7.2.2.3 FETAL BOVINE SERA

7.2.2.4 ADULT BOVINE SERA

7.2.2.5 OTHERS ANIMAL SERA

7.2.3 REAGENTS

7.2.3.1 SUPPLEMENTS & GROWTH FACTORS

7.2.3.2 BUFFERS & CHEMICALS

7.2.3.3 CELL DISASSOCIATION REAGENTS

7.2.3.4 BALANCED SALT SOLUTIONS

7.2.3.5 ATTACHMENT & MATRIX FACTORS

7.2.3.6 ANTIBIOTICS/ANTIMYCOTICS

7.2.3.7 CONTAMINATION DETECTION KITS

7.2.3.8 CRYOPROTECTIVE REAGENTS

7.2.3.9 OTHERS CELL CULTURE REAGENTS

7.2.4 ACCESSORIES

7.3 INSTRUMENTS

7.3.1 SUPPORTING EQUIPMENTS

7.3.1.1 CELL COUNTERS

7.3.1.2 IMAGE BASED CELL COUNTERS

7.3.1.3 FLOW CYTOMETERS

7.3.1.4 COULTER COUNTERS

7.3.1.5 CELL EXPANSION

7.3.1.6 LIQUID HANDLERS

7.3.1.7 OTHERS

7.3.2 BIOREACTORS

7.3.2.1 SINGLE USE BIOREACTORS

7.3.2.2 CONVENTIONAL BIOREACTORS

7.3.2.3 OTHERS

7.3.3 STORAGE EQUIPMENTS

7.3.3.1 REFRIGERATORS & FREEZERS

7.3.3.2 CRYOSTORAGE SYSTEMS

7.3.3.3 OTHERS

8 EUROPE AUTOMATED CELL CULTURES MARKET, BY TYPE

8.1 OVERVIEW

8.2 INFINITE CELL LINE CULTURES

8.3 FINITE CELL LINE CULTURES

9 EUROPE AUTOMATED CELL CULTURES MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 DRUG DEVELOPMENT

9.3 STEM CELL RESEARCH

9.3.1 EMBRYONIC STEM CELLS

9.3.2 TISSUE-SPECIFIC STEM CELLS

9.3.3 MESENCHYMAL STEM CELLS

9.3.4 INDUCED PLURIPOTENT STEM CELLS

9.4 REGENERATIVE MEDICINE

9.4.1 STEM CELL THERAPY

9.4.2 PLATELET-RICH PLASMA THERAPY (OR PRP INJECTIONS)

9.4.3 TISSUE ENGINEERING

9.4.4 AMNIOTIC-MEMBRANE DERIVED STEM CELLS

9.5 CANCER RESEARCH

9.6 VACCINES

9.7 OTHERS

10 EUROPE AUTOMATED CELL CULTURES MARKET, BY END USER

10.1 OVERVIEW

10.2 BIOTECH COMPANIES

10.3 RESEARCH ORGANIZATIONS

10.4 ACADEMIC RESEARCH INSTITUTES

10.5 OTHERS

11 EUROPE AUTOMATED CELL CULTURES MARKET, BY REGION

11.1 EUROPE

11.1.1 GERMANY

11.1.2 U.K.

11.1.3 FRANCE

11.1.4 RUSSIA

11.1.5 ITALY

11.1.6 TURKEY

11.1.7 NETHERLANDS

11.1.8 SWITZERLAND

11.1.9 SPAIN

11.1.10 BELGIUM

11.1.11 REST OF EUROPE

12 EUROPE AUTOMATED CELL CULTURES MARKET: COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: EUROPE

13 COMPANY PROFILE

13.1 LONZA

13.1.1 COMPANY SNAPSHOT

13.1.2 REVENUE ANALYSIS

13.1.3 COMPANY SHARE ANALYSIS

13.1.4 PRODUCT PORTFOLIO

13.1.5 RECENT DEVELOPMENTS

13.1.6 SWOT ANALYSIS

13.2 MERCK KGAA

13.2.1 COMPANY SNAPSHOT

13.2.2 RECENT FINANCIALS

13.2.3 COMPANY SHARE ANALYSIS

13.2.4 PRODUCT PORTFOLIO

13.2.5 RECENT DEVELOPMENTS

13.2.6 SWOT ANALYSIS

13.3 THERMO FISHER SCIENTIFIC INC.

13.3.1 COMPANY SNAPSHOT

13.3.2 RECENT FINANCIALS

13.3.3 COMPANY SHARE ANALYSIS

13.3.4 PRODUCT PORTFOLIO

13.3.5 RECENT DEVELOPMENTS

13.3.6 SWOT ANALYSIS

13.4 BD

13.4.1 COMPANY SNAPSHOT

13.4.2 RECENT FINANCIALS

13.4.3 COMPANY SHARE ANALYSIS

13.4.4 PRODUCT PORTFOLIO

13.4.5 RECENT DEVELOPMENTS

13.4.6 SWOT ANALYSIS

13.5 EPPENDORF AG

13.5.1 COMPANY SNAPSHOT

13.5.2 REVENUE ANALYSIS

13.5.3 COMPANY SHARE ANALYSIS

13.5.4 PRODUCT PORTFOLIO

13.5.5 RECENT DEVELOPMENTS

13.5.6 SWOT ANALYSIS

13.6 ADVANCED INSTRUMENTS

13.6.1 COMPANY SNAPSHOT

13.6.2 PRODUCT PORTFOLIO

13.6.3 RECENT DEVELOPMENTS

13.7 BENCHMARK SCIENTIFIC INC.

13.7.1 COMPANY SNAPSHOT

13.7.2 PRODUCT PORTFOLIO

13.7.3 RECENT DEVELOPMENTS

13.8 BIOSPHERIX LTD.

13.8.1 COMPANY SNAPSHOT

13.8.2 PRODUCT PORTFOLIO

13.8.3 RECENT DEVELOPMENTS

13.9 BIOTRON HEALTHCARE

13.9.1 COMPANY SNAPSHOT

13.9.2 PRODUCT PORTFOLIO

13.9.3 RECENT DEVELOPMENTS

13.1 BULLDOG-BIO, INC.

13.10.1 COMPANY SNAPSHOT

13.10.2 PRODUCT PORTFOLIO

13.11 CELL CULTURE COMPANY, LLC

13.11.1 COMPANY SNAPSHOT

13.11.2 PRODUCT PORTFOLIO

13.11.3 RECENT DEVELOPMENT

13.12 CELLGENIX GMBH

13.12.1 COMPANY SNAPSHOT

13.12.2 PRODUCT PORTFOLIO

13.12.3 RECENT DEVELOPMENTS

13.13 CHEMOMETEC

13.13.1 COMPANY SNAPSHOT

13.13.2 REVENUE ANALYSIS

13.13.3 PRODUCT PORTFOLIO

13.13.4 RECENT DEVELOPMENT

13.14 CORNING INCORPORATED

13.14.1 COMPANY SNAPSHOT

13.14.2 RECENT FINANCIALS

13.14.3 PRODUCT PORTFOLIO

13.14.4 RECENT DEVELOPMENTS

13.15 CYTIVA (SUBSIDIARY OF DANAHER CORPORATION)

13.15.1 COMPANY SNAPSHOT

13.15.2 REVENUE ANALYSIS

13.15.3 PRODUCT PORTFOLIO

13.15.4 RECENT DEVELOPMENTS

13.16 FUJIFILM HOLDINGS AMERICA CORPORATION

13.16.1 COMPANY SNAPSHOT

13.16.2 REVENUE ANALYSIS

13.16.3 PRODUCT PORTFOLIO

13.16.4 RECENT DEVELOPMENTS

13.17 HAMILTON COMPANY

13.17.1 COMPANY SNAPSHOT

13.17.2 PRODUCT PORTFOLIO

13.17.3 RECENT DEVELOPMENTS

13.18 HITACHI, LTD.

13.18.1 COMPANY SNAPSHOT

13.18.2 REVENUE ANALYSIS

13.18.3 PRODUCT PORTFOLIO

13.18.4 RECENT DEVELOPMENTS

13.19 KAWASAKI HEAVY INDUSTRIES, LTD.

13.19.1 COMPANY SNAPSHOT

13.19.2 REVENUE ANALYSIS

13.19.3 PRODUCT PORTFOLIO

13.19.4 RECENT DEVELOPMENTS

13.2 HIMEDIA LABORATORIES

13.20.1 COMPANY SNAPSHOT

13.20.2 PRODUCT PORTFOLIO

13.20.3 RECENT DEVELOPMENTS

13.21 NANOENTEK AMERICA INC. (A SUBSIDIARY OF NANOENTEK)

13.21.1 COMPANY SNAPSHOT

13.21.2 PRODUCT PORTFOLIO

13.21.3 RECENT DEVELOPMENTS

13.22 NEXCELOM BIOSCIENCE LLC.

13.22.1 COMPANY SNAPSHOT

13.22.2 PRODUCT PORTFOLIO

13.22.3 RECENT DEVELOPMENTS

13.23 PROMOCELL GMBH

13.23.1 COMPANY SNAPSHOT

13.23.2 PRODUCT PORTFOLIO

13.23.3 RECENT DEVELOPMENTS

13.24 RWD LIFE SCIENCE CO LTD.

13.24.1 COMPANY SNAPSHOT

13.24.2 PRODUCT PORTFOLIO

13.24.3 RECENT DEVELOPMENTS

13.25 SARTORIUS AG

13.25.1 COMPANY SNAPSHOT

13.25.2 REVENUE ANALYSIS

13.25.3 PRODUCT PORTFOLIO

13.25.4 RECENT DEVELOPMENTS

13.26 SCIENTICA INSTRUMENTATION, INC.

13.26.1 COMPANY SNAPSHOT

13.26.2 PRODUCT PORTFOLIO

13.26.3 RECENT DEVELOPMENTS

13.27 SHIBUYA CORPORATION

13.27.1 COMPANY SNAPSHOT

13.27.2 RECENT FINANCIALS

13.27.3 PRODUCT PORTFOLIO

13.27.4 RECENT DEVELOPMENTS

13.28 SPHERE FLUIDICS LIMITED

13.28.1 COMPANY SNAPSHOT

13.28.2 PRODUCT PORTFOLIO

13.28.3 RECENT DEVELOPMENTS

13.29 TECAN TRADING AG

13.29.1 COMPANY SNAPSHOT

13.29.2 RECENT FINANCIALS

13.29.3 PRODUCT PORTFOLIO

13.29.4 RECENT DEVELOPMENT

13.3 THRIVE BIOSCIENCE, INC.

13.30.1 COMPANY SNAPSHOT

13.30.2 PRODUCT PORTFOLIO

13.30.3 RECENT DEVELOPMENTS

14 QUESTIONNAIRE

15 RELATED REPORTS

Lista de Tablas

TABLE 1 EUROPE AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 2 EUROPE CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 3 EUROPE CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 4 EUROPE MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 5 EUROPE BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 6 EUROPE REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCTS, 2020-2029 (EURO MILLION)

TABLE 7 EUROPE INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 8 EUROPE INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 9 EUROPE SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 10 EUROPE BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 11 EUROPE STORAGE EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 12 EUROPE AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)

TABLE 13 EUROPE INFINITE CELL LINE CULTURES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 14 EUROPE FINITE CELL LINE CULTURES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 15 EUROPE AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 16 EUROPE DRUG DEVELOPMENT IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 17 EUROPE STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 18 EUROPE STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 19 EUROPE REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 20 EUROPE REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 21 EUROPE CANCER RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 22 EUROPE VACCINES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 23 EUROPE OTHERS IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 24 EUROPE AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)

TABLE 25 EUROPE BIOTECH COMPANIES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 26 EUROPE RESEARCH ORGANIZATIONS IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 27 EUROPE ACADEMIC RESEARCH INSTITUTES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 28 EUROPE OTHERS IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 29 EUROPE AUTOMATED CELL CULTURES MARKET, BY COUNTRY, 2020-2029 (EURO MILLION)

TABLE 30 EUROPE AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 31 EUROPE CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 32 EUROPE MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 33 EUROPE BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 34 EUROPE REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 35 EUROPE INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 36 EUROPE SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 37 EUROPE BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 38 EUROPE STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 39 EUROPE AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)

TABLE 40 EUROPE AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 41 EUROPE STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 42 EUROPE REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 43 EUROPE AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)

TABLE 44 GERMANY AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 45 GERMANY CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 46 GERMANY MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 47 GERMANY BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 48 GERMANY REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 49 GERMANY INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 50 GERMANY SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 51 GERMANY BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 52 GERMANY STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 53 GERMANY AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)

TABLE 54 GERMANY AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 55 GERMANY STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 56 GERMANY REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 57 GERMANY AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)

TABLE 58 U.K. AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 59 U.K. CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 60 U.K. MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 61 U.K. BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 62 U.K. REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 63 U.K. INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 64 U.K. SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 65 U.K. BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 66 U.K. STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 67 U.K. AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)

TABLE 68 U.K. AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 69 U.K. STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 70 U.K. REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 71 U.K. AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)

TABLE 72 FRANCE AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 73 FRANCE CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 74 FRANCE MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 75 FRANCE BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 76 FRANCE REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 77 FRANCE INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 78 FRANCE SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 79 FRANCE BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 80 FRANCE STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 81 FRANCE AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)

TABLE 82 FRANCE AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 83 FRANCE STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 84 FRANCE REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 85 FRANCE AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)

TABLE 86 RUSSIA AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 87 RUSSIA CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 88 RUSSIA MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 89 RUSSIA BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 90 RUSSIA REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 91 RUSSIA INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 92 RUSSIA SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 93 RUSSIA BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 94 RUSSIA STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 95 RUSSIA AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)

TABLE 96 RUSSIA AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 97 RUSSIA STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 98 RUSSIA REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 99 RUSSIA AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)

TABLE 100 ITALY AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 101 ITALY CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 102 ITALY MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 103 ITALY BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 104 ITALY REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 105 ITALY INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 106 ITALY SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 107 ITALY BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 108 ITALY STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 109 ITALY AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)

TABLE 110 ITALY AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 111 ITALY STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 112 ITALY REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 113 ITALY AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)

TABLE 114 TURKEY AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 115 TURKEY CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 116 TURKEY MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 117 TURKEY BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 118 TURKEY REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 119 TURKEY INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 120 TURKEY SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 121 TURKEY BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 122 TURKEY STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 123 TURKEY AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)

TABLE 124 TURKEY AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 125 TURKEY STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 126 TURKEY REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 127 TURKEY AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)

TABLE 128 NETHERLANDS AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 129 NETHERLANDS CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 130 NETHERLANDS MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 131 NETHERLANDS BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 132 NETHERLANDS REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 133 NETHERLANDS INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 134 NETHERLANDS SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 135 NETHERLANDS BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 136 NETHERLANDS STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 137 NETHERLANDS AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)

TABLE 138 NETHERLANDS AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 139 NETHERLANDS STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 140 NETHERLANDS REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 141 NETHERLANDS AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)

TABLE 142 SWITZERLAND AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 143 SWITZERLAND CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 144 SWITZERLAND MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 145 SWITZERLAND BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 146 SWITZERLAND REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 147 SWITZERLAND INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 148 SWITZERLAND SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 149 SWITZERLAND BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 150 SWITZERLAND STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 151 SWITZERLAND AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)

TABLE 152 SWITZERLAND AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 153 SWITZERLAND STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 154 SWITZERLAND REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 155 SWITZERLAND AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)

TABLE 156 SPAIN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 157 SPAIN CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 158 SPAIN MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 159 SPAIN BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 160 SPAIN REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 161 SPAIN INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 162 SPAIN SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 163 SPAIN BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 164 SPAIN STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 165 SPAIN AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)

TABLE 166 SPAIN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 167 SPAIN STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 168 SPAIN REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 169 SPAIN AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)

TABLE 170 BELGIUM AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 171 BELGIUM CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 172 BELGIUM MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 173 BELGIUM BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 174 BELGIUM REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 175 BELGIUM INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 176 BELGIUM SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 177 BELGIUM BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 178 BELGIUM STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 179 BELGIUM AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)

TABLE 180 BELGIUM AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 181 BELGIUM STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 182 BELGIUM REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 183 BELGIUM AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)

TABLE 184 REST OF EUROPE AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

Lista de figuras

FIGURE 1 EUROPE AUTOMATED CELL CULTURES MARKET: SEGMENTATION

FIGURE 2 EUROPE AUTOMATED CELL CULTURES MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE AUTOMATED CELL CULTURES MARKET: DROC ANALYSIS

FIGURE 4 EUROPE AUTOMATED CELL CULTURES MARKET: EUROPE VS REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE AUTOMATED CELL CULTURES MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE AUTOMATED CELL CULTURES MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE AUTOMATED CELL CULTURES MARKET: DBMR MARKET POSITION GRID

FIGURE 8 EUROPE AUTOMATED CELL CULTURES MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 9 EUROPE AUTOMATED CELL CULTURES MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE AUTOMATED CELL CULTURES MARKET: SEGMENTATION

FIGURE 11 WIDE ACCEPTANCE OF CELL CULTURE TECHNIQUES IN VARIOUS APPLICATIONS AND THE GROWING BIOTECHNOLOGY SECTOR ARE EXPECTED TO DRIVE THE EUROPE AUTOMATED CELL CULTURES MARKET IN THE FORECAST PERIOD

FIGURE 12 CONSUMABLES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE AUTOMATED CELL CULTURES MARKET IN 2022 & 2029

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF EUROPE AUTOMATED CELL CULTURES MARKET

FIGURE 14 EUROPE AUTOMATED CELL CULTURES MARKET: BY PRODUCT, 2021

FIGURE 15 EUROPE AUTOMATED CELL CULTURES MARKET: BY PRODUCT, 2022-2029 (EURO MILLION)

FIGURE 16 EUROPE AUTOMATED CELL CULTURES MARKET: BY PRODUCT, CAGR (2022-2029)

FIGURE 17 EUROPE AUTOMATED CELL CULTURES MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 18 EUROPE AUTOMATED CELL CULTURES MARKET: BY TYPE, 2021

FIGURE 19 EUROPE AUTOMATED CELL CULTURES MARKET: BY TYPE, 2022-2029 (EURO MILLION)

FIGURE 20 EUROPE AUTOMATED CELL CULTURES MARKET: BY TYPE, CAGR (2022-2029)

FIGURE 21 EUROPE AUTOMATED CELL CULTURES MARKET: BY TYPE, LIFELINE CURVE

FIGURE 22 EUROPE AUTOMATED CELL CULTURES MARKET: BY APPLICATION, 2021

FIGURE 23 EUROPE AUTOMATED CELL CULTURES MARKET: BY APPLICATION, 2022-2029 (EURO MILLION)

FIGURE 24 EUROPE AUTOMATED CELL CULTURES MARKET: BY APPLICATION, CAGR (2022-2029)

FIGURE 25 EUROPE AUTOMATED CELL CULTURES MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 26 EUROPE AUTOMATED CELL CULTURES MARKET: BY END USER, 2021

FIGURE 27 EUROPE AUTOMATED CELL CULTURES MARKET: BY END USER, 2022-2029 (EURO MILLION)

FIGURE 28 EUROPE AUTOMATED CELL CULTURES MARKET: BY END USER, CAGR (2022-2029)

FIGURE 29 EUROPE AUTOMATED CELL CULTURES MARKET: BY END USER, LIFELINE CURVE

FIGURE 30 EUROPE AUTOMATED CELL CULTURES MARKET : SNAPSHOT (2021)

FIGURE 31 EUROPE AUTOMATED CELL CULTURES MARKET: BY COUNTRY (2021)

FIGURE 32 EUROPE AUTOMATED CELL CULTURES MARKET: BY COUNTRY (2022 & 2029)

FIGURE 33 EUROPE AUTOMATED CELL CULTURES MARKET: BY COUNTRY (2021 & 2029)

FIGURE 34 EUROPE AUTOMATED CELL CULTURES MARKET : BY PRODUCT (2022-2029)

FIGURE 35 EUROPE AUTOMATED CELL CULTURES MARKET: COMPANY SHARE 2021 (%)

Ver información detallada Right Arrow

Metodología de investigación

La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.

La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.

Personalización disponible

Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados ​​en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.